300199 翰宇药业
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)11.623-25.968-50.642-25.9551.912
总资产报酬率 ROA (%)2.310-5.526-14.920-9.8580.777
投入资产回报率 ROIC (%)2.745-6.471-17.110-11.2470.873

边际利润分析
销售毛利率 (%)59.84557.09249.30677.33672.042
营业利润率 (%)13.507-27.344-117.646-52.6475.313
息税前利润/营业总收入 (%)25.201-8.212-89.442-37.66917.970
净利润/营业总收入 (%)10.212-30.514-119.486-52.8953.864

收益指标分析
经营活动净收益/利润总额(%)85.86272.55789.42659.104-701.260
价值变动净收益/利润总额(%)3.284-0.952-6.79024.0781,105.394
营业外收支净额/利润总额(%)-5.3170.6320.7040.539-16.096

偿债能力分析
流动比率 (X)0.3730.3250.4800.7081.553
速动比率 (X)0.1830.1580.3730.5421.342
资产负债率 (%)78.99280.15376.10164.08657.813
带息债务/全部投入资本 (%)71.39172.01468.75155.19549.725
股东权益/带息债务 (%)33.89631.93338.71772.94492.826
股东权益/负债合计 (%)25.91923.99830.42554.90470.167
利息保障倍数 (X)2.036-0.425-3.080-2.4681.342

营运能力分析
应收账款周转天数 (天)37.07672.623189.181148.743143.063
存货周转天数 (天)259.260278.077281.953391.397300.840